12 West Capital Management’s Bio-Techne TECH Stock Holding History

12 West Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-210,592	Closed	-$15M	–	27
2022 Q3	$15M	Buy	+210,592	New	+$18.2M	1.32%	14
2019 Q4	–	Sell	-1,424,848	Closed	-$69.7M	–	17
2019 Q3	$69.7M	Hold	1,424,848	–	–	4.49%	7
2019 Q2	$74.3M	Hold	1,424,848	–	–	5.59%	5
2019 Q1	$70.7M	Buy	1,424,848 +140,000	+11%	+$6.3M	5.77%	5
2018 Q4	$46.5M	Buy	1,284,848 +120,000	+10%	+$5.01M	4.79%	7
2018 Q3	$59.4M	Buy	+1,164,848	New	+$51.6M	4.36%	9

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

12 West Capital Management's TECH Position: Q4 2022 in Review

12 West Capital Management sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 210,592 shares — an estimated $15M sold.

12 West Capital Management first reported a position in TECH in Q3 2018 and held it in 6 quarters. The position peaked at $74.3M in Q2 2019. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

12 West Capital Management reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
12 West Capital Management sold 210,592 Bio-Techne shares in Q4 2022, an estimated $15M.
12 West Capital Management first reported a position in Bio-Techne in Q3 2018 and held it in 6 quarters.
12 West Capital Management's Bio-Techne position peaked at $74.3M in Q2 2019.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on 12 West Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.